COVAX

Factbox: Vaccines delivered under COVAX sharing scheme for poorer countries

July 1 (Reuters) – The COVAX facility, backed by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), has delivered 1.55 billion COVID-19 vaccine doses to 146 countries, GAVI data shows.

In December, COVAX set a target of achieving 70% COVID-19 immunization coverage by mid-2022.

The following tables list countries that have received vaccines under the scheme in alphabetic order:

AFRICA & MIDDLE EAST

COUNTRY
LATEST DELIVERY
DELIVERY DATE
VACCINE
TYPE
POPULATION
TOTAL DELIVERED
Algeria
3.6 million
December 24
J&J
44 million
6.0 million
Angola
801,000
December 25
Pfizer/BioNTech
33 million
14.8 million
Benin
336,000
November 4
J&J
12 million
1.1 million
Botswana
300,000
October 1
AstraZeneca/
Oxford
2.5 million
560,460
Burkina Faso
700,000
May 1
Pfizer/BioNTech
21 million
1.8 million
Cameroon
68,600
April 1
AstraZeneca/
Oxford
27 million
1.1 million
Cape Verde
200,000
December 7
Pfizer/BioNTech
556,000
324,000
Central African Republic
168,300
March 4
N/A
4.8 million
975,000
Chad
828,000
March 24
J&J
16 million
1.0 million
Comoros Islands
90,000
May 8
Pfizer/BioNTech
870,000
360,810
Congo
168,000
November 15
J&J
5.5 million
470,400
Democratic Republic of Congo
2.1 million
June 28
N/A
90 million
4.7 million
Djibouti
151,200
July 17
J&J
988,000
175,200
Egypt
1.5 million
April 7
Pfizer/BioNTech
102 million
30.5 million
Eswatini
100,620
October 6
Pfizer/BioNTech
1.1 million
429,420
Equatorial Guinea
60,480
June 1
Moderna
1.4 million
60,480
Ethiopia
13.1 million
February 2
J&J
115 million
27.5 million
Gabon
101,790
November 1
Pfizer/BioNTech
2.2 million
370,410
Gambia
100,620
March 3
Pfizer/BioNTech
2.4 million
477,420
Ghana
309,600
March 14
AstraZeneca/Oxford
31 million
16.6 million
Guinea
168,000
November 14
J&J
13 million
1.7 million
Guinea-Bissau
136,800
March 25
J&J
2.0 million
496,800
Iran
700,000
January 14
AstraZeneca/Oxford
84 million
5.7 million
Iraq
500,000
August 14
Pfizer/BioNTech
40 million
836,000
Ivory Coast
816,660
January 3
Pfizer/BioNTech
26 million
8.6 million
Jordan
146,400
June 3
AstraZeneca/Oxford
10 million
436,800
Kenya
500,000
May 10
Pfizer/BioNTech
54 million
20.3 million
Lebanon
613,340
December 22
N/A
6.8 million
982,940
Lesotho
169,070
November 19
J&J
2.1 million
644,090
Liberia
583,200
June 1
J&J
5.1 million
2.0 million
Libya
1.2 million
December 20
Pfizer/BioNTech
6.9 million
1.9 million
Madagascar
240,000
February 17
J&J
28 million
1.9 million
Malawi
277,080
February 26
AstraZeneca/Oxford
19 million
2.0 million
Mali
58,500
June 15
Pfizer/BioNTech
20 million
2.8 million
Mauritania
57,330
June 2
Pfizer/BioNTech
4.6 million
2.2 million
Mauritius
203,580
January 12
Pfizer/BioNTech
1.3 million
387,270
Morocco
1.5 million
January 29
Pfizer/BioNTech
37 million
2.7 million
Mozambique
1.2 million
February 11
AstraZeneca/Oxford
31 million
8.4 million
Namibia
19,890
February 18
Pfizer/BioNTech
2.5 million
512,690
Niger
398,000
February 4
Pfizer/BioNTech
24 million
1.6 million
Nigeria
2.0 million
February 7
J&J
206 million
17.2 million
Palestinian Territories
299,520
April 27
Pfizer/BioNTech
4.7 million
1.6 million
Rwanda
254,400
June 27
N/A
13 million
4.2 million
Sao Tome and Principe
24,000
March 3
AstraZeneca/Oxford
219,000
24,000
Senegal
300,000
March 31
AstraZeneca/Oxford
17 million
3.5 million
Seychelles
39,780
December 17
Pfizer/BioNTech
98,460
74,880
Sierra Leone
168,000
November 23
J&J
8.0 million
785,310
Somalia
286,650
May 25
Pfizer/BioNTech
16 million
1.7 million
South Africa
5.6 million
July 31
Pfizer/BioNTech
59 million
5.6 million
South Sudan
949,500
April 5
N/A
11 million
1.9 million
Sudan
604,800
February 16
J&J
44 million
3.9 million
Syria
4.0 million
January 26
J&J
17 million
5.7 million
Tanzania
2.6 million
June 9
J&J
60 million
7.5 million
Togo
633,600
November 25
J&J
8.3 million
3.0 million
Tunisia
599,040
March 31
N/A
12 million
5.4 million
Uganda
2.9 million
March 9
J&J
46 million
14.6 million
Yemen
100,800
February 24
AstraZeneca/Oxford
30 million
2.2 million
Zambia
950,350
June 30
J&J
18 million
5.4 million
Zimbabwe
2.6 million
January 19
N/A
15 million
3.5 million

EUROPE

COUNTRY
LATEST DELIVERY
DELIVERY DATE
VACCINE TYPE
POPULATION
TOTAL DELIVERED
Albania
40,800
June 2
AstraZeneca/Oxford
2.8 million
120,000
Armenia
187,200
September 5
AstraZeneca/Oxford
3.0 million
261,200
Azerbaijan
84,000
April 4
AstraZeneca/Oxford
10 million
84,000
Bosnia
32,760
May 10
Pfizer/BioNTech
3.3 million
82,560
Georgia
43,200
March 13
AstraZeneca/Oxford
3.7 million
43,200
Kosovo
4,800
June 22
N/A
1.8 million
1.2 million
Moldova
100,620
January 27
Pfizer/BioNTech
2.6 million
744,620
Montenegro
24,000
March 28
AstraZeneca/Oxford
622,000
24,000
North Macedonia
250,380
February 7
Pfizer/BioNTech
2.1 million
312,780
Serbia
115,200
August 25
AstraZeneca/Oxford
6.9 million
292,800
Ukraine
1.0 million
January 19
Pfizer/BioNTech
44 million
8.8 million

ASIA & PACIFIC

COUNTRY
LATEST DELIVERY
DELIVERY DATE
VACCINE TYPE
POPULATION
TOTAL DELIVERED
Afghanistan
2.0 million
February 2
J&J
39 million
9.0 million
Bangladesh
4.1 million
June 27
N/A
165 million
38.9 million
Bhutan
90,090
April 5
Pfizer/BioNTech
771,612
90,090
Brunei
24,000
April 2
AstraZeneca/Oxford
437,000
24,000
Cambodia
2.0 million
May 3
Pfizer/BioNTech
17 million
4.9 million
East Timor
100,620
February 12
Pfizer/BioNTech
1.3 million
494,040
Fiji
9,600
June 29
Moderna
896,000
312,080
Indonesia
3.5 million
March 5
Pfizer/BioNTech
274 million
52.3 million
Kiribati
23,400
June 6
Pfizer/BioNTech
119,000
127,400
Kyrgyzstan
149,760
February 1
Pfizer/BioNTech
6.6 million
800,300
Laos
1.7 million
January 26
Pfizer/BioNTech
7.3 million
7.6 million
Malaysia
559,200
September 17
AstraZeneca/Oxford
32 million
1.4 million
Maldives
210,600
January 28
Pfizer/BioNTech
541,000
664,540
Mongolia
302,400
June 21
Pfizer/BioNTech
3.3 million
1.6 million
Nauru
7,200
April 2
AstraZeneca/Oxford
10,830
7,200
Nepal
1.5 million
March 31
Pfizer/BioNTech
29 million
15.7 million
Pakistan
4.7 million
April 12
Pfizer/BioNTech
221 million
43.8 million
Papua New Guinea
302,400
August 6
J&J
8.9 million
580,400
Philippines
299,520
June 27
Pfizer/BioNTech
110 million
56.9 million
Samoa
45,630
May 2
Pfizer/BioNTech
198,410
181,630
Solomon Islands
52,650
April 11
N/A
687,000
262,070
Sri Lanka
820,000
December 20
Pfizer/BioNTech
22 million
5.0 million
Tajikistan
198,900
June 1
Pfizer/BioNTech
9.5 million
6.5 million
Tonga
7,000
February 15
N/A
106,000
67,800
Tuvalu
4,800
April 8
AstraZeneca/Oxford
11,800
4,800
Uzbekistan
2.1 million
March 28
Moderna
34 million
19.0 million
Vanuatu
20,400
April 8
Moderna
307,000
44,400
Vietnam
3.5 million
April 19
Pfizer/BioNTech
97 million
50.0 million

AMERICAS

COUNTRY
LATEST DELIVERY
DELIVERY DATE
VACCINE TYPE
POPULATION
TOTAL DELIVERED
Antigua and Barbuda
19,200
November 22
N/A
98,000
60,000
Argentina
960,400
October 12
AstraZeneca/Oxford
45 million
3.9 million
Bahamas
57,330
October 18
Pfizer/BioNTech
393,000
124,530
Barbados
14,040
December 16
Pfizer/BioNTech
287,000
114,840
Belize
58,500
October 26
Pfizer/BioNTech
398,000
159,300
Bermuda
9,600
April 6
AstraZeneca/Oxford
64,000
9,600
Bolivia
603,720
April 28
Pfizer/BioNTech
12 million
8.6 million
Brazil
2.0 million
September 20
Sinovac
213 million
11.9 million
Chile
331,000
May 20
AstraZeneca/Oxford
19 million
489,400
Colombia
2.3 million
March 23
Pfizer/BioNTech
51 million
18.9 million
Costa Rica
200,070
February 28
Pfizer/BioNTech
5.1 million
1.6 million
Dominica
30,240
February 4
Moderna
72,000
133,920
Dominican Republic
184,800
August 27
AstraZeneca/Oxford
11 million
463,200
Ecuador
1.5 million
February 15
Pfizer/BioNTech
18 million
3.8 million
El Salvador
188,370
August 27
Pfizer/BioNTech
6.5 million
3.6 million
Grenada
5,040
June 8
Moderna
113,000
124,710
Guatemala
349,830
June 27
Pfizer/BioNTech
17 million
5.9 million
Guyana
28,800
January 14
J&J
787,000
291,540
Haiti
60,000
June 27
J&J
11 million
1.1 million
Honduras
153,600
June 30
Pfizer/BioNTech
9.9 million
5.7 million
Jamaica
398,970
March 21
Pfizer/BioNTech
3.0 million
1.9 million
Mexico
4.0 million
March 4
AstraZeneca/Oxford
129 million
21.3 million
Nicaragua
657,540
June 24
Pfizer/BioNTech
6.6 million
5.4 million
Panama
74,400
September 15
AstraZeneca/Oxford
4.3 million
148,800
Paraguay
466,830
January 24
Pfizer/BioNTech
7.1 million
1.7 million
Peru
1.2 million
November 10
Sinopharm
33 million
3.6 million
Saint Kitts and Nevis
21,600
April 7
AstraZeneca/Oxford
53,000
21,600
Saint Lucia
5,040
March 16
Moderna
184,000
202,470
Saint Vincent and the Grenadines
70,200
December 14
Pfizer/BioNTech
111,000
115,800
Suriname
64,800
December 14
AstraZeneca/Oxford
587,000
144,000
Trinidad and Tobago
84,000
November 27
Sinopharm
1.4 million
185,200
Uruguay
50,400
September 1
AstraZeneca/Oxford
3.5 million
148,800
Venezuela
4.7 million
March 14
Sinopharm
28 million
16.8 million

Sources: WHO, UNICEF, GAVI, releases from local authorities

Compiled by Marta Frackowiak, Antonis Pothitos, Boleslaw Lasocki, Antonis Triantafyllou, Aleksandra Jasiurska and Elizaveta Gladun Editing by Milla Nissi, William Maclean, Mark Potter, Barbara Lewis and Shinjini Ganguli

Our Standards: The Thomson Reuters Trust Principles.